Orencia 125 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F9PL5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,863
Award facts
- Contract value 100% obligated
- $12,863.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,863.27 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of February 5, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant used in the treatment of rheumatoid arthritis and other autoimmune conditions, representing a specialized pharmaceutical supply need within the federal medical procurement system.
This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2031. This prime IDC enables the contractor to supply a broad spectrum of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities—to support military healthcare programs worldwide. The structure allows AmerisourceBergen to efficiently fulfill critical pharmaceutical needs for military treatment facilities, the Defense Health Agency, and other federal medical institutions through flexible task order arrangements.
Quick answers
Who was awarded contract SPE2DR26F9PL5?
SPE2DR26F9PL5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F9PL5 worth?
The government has obligated $12,863 on SPE2DR26F9PL5.
Is contract SPE2DR26F9PL5 an order under another contract?
Yes. SPE2DR26F9PL5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9PL5 competed?
The extent of competition for SPE2DR26F9PL5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award